β1-Adrenergic receptor polymorphisms, QTc interval and occurrence of symptoms in type 1 of long QT syndrome

Abstract Background The most prevalent LQT1 form of inherited long QT syndrome is caused by mutations of the KCNQ1 gene resulting repolarizing IKs potassium current to decrease and the QT interval to prolong. As abrupt sympathetic activation triggers ventricular arrhythmias that may cause syncopal a...

Full description

Saved in:
Bibliographic Details
Published in:International journal of cardiology 2007-05, Vol.118 (2), p.197-202
Main Authors: Paavonen, Kristian J, Swan, Heikki, Piippo, Kirsi, Laitinen, Päivi, Fodstad, Heidi, Sarna, Seppo, Toivonen, Lauri, Kontula, Kimmo, Viitasalo, Matti
Format: Article
Language:English
Subjects:
Beta-adrenergic receptor
Biological and medical sciences
Cardiac dysrhythmias
Cardiology. Vascular system
Cardiovascular
Heart
Long QT syndrome
Medical sciences
Polymorphism
Potassium channel
QT interval
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background The most prevalent LQT1 form of inherited long QT syndrome is caused by mutations of the KCNQ1 gene resulting repolarizing IKs potassium current to decrease and the QT interval to prolong. As abrupt sympathetic activation triggers ventricular arrhythmias that may cause syncopal attacks and sudden death in LQT1 patients, we investigated whether two known β1-adrenergic receptor polymorphisms were associated with the duration of QT interval or history of symptoms in LQT1. Methods We determined β1-adrenergic receptor polymorphisms (Ser49Gly and Arg389Gly) in 168 LQT1 patients. We also reviewed each patient's clinical records on the history of long QT syndrome-related symptoms and measured QT intervals from baseline ECG in each subject and from an exercise test ECG in 55 LQT1 patients. Results Patients with the homozygous Arg389Arg genotype tended to have shorter and those with the Ser49Ser genotype longer QT intervals than patients with other genotypes, but neither polymorphism studied alone affected the risk of symptoms. In contrast, adjusted odds ratio for the history of symptoms was 4.9 (95% CI 1.18 to 20.3) in patients homozygous for both Ser49 and Arg389. These double homozygous patients showed similar QT intervals as the rest of the LQT1 cohort. Conclusions In this relatively small study, double homozygosity for Arg389 and Ser49 of the human β1-adrenergic receptor associated with the risk of symptoms in LQT1. The association between these β1-adrenergic receptor polymorphisms and the symptom history in LQT1 is not mediated via QT interval duration.
ISSN:0167-5273
1874-1754
DOI:10.1016/j.ijcard.2006.06.050